H. Prosch (Wien, Austria), Á. Tárnoki (Budapest, Hungary)
Introduction
|  |
Machine Learning analysis of human pulmonary extracellular matrix architecture identifies disease-specific remodeling patterns
T. Lund (Copenhagen, Denmark), M. Emerson (Copenhagen, Denmark), O. Willacy (Copenhagen, Denmark), C. Madsen (Lund, Sweden), R. Reuten (Freiburg, Germany), C. Brøchner (Copenhagen, Denmark), A. Dahl (Copenhagen, Denmark), T. Jensen (Copenhagen, Denmark), J. Erler (Copenhagen, Denmark), A. Mayorca-Guiliani (Copenhagen, Denmark)
|   |
Airway inter-tapering and tortuosity predict mortality in idiopathic pulmonary fibrosis
W. Cheung (London, United Kingdom), A. Pakzad (London, United Kingdom), N. Mogulkoc (Izmir, Turkey), R. Savas (Izmir, Turkey), D. Alexander (London, United Kingdom), Y. Hu (London, United Kingdom), J. Hurst (London, United Kingdom), J. Jacob (London, United Kingdom)
|  |
Ultra-high-resolution photon-counting CT of the lungs: a comparative study
V. Van Ballaer (Leuven, Belgium), A. Dubbeldam (Leuven, Belgium), L. Cockmartin (Leuven, Belgium), E. Muscogiuri (Leuven, Belgium), J. Coolen (Leuven, Belgium), W. Coudyzer (Leuven, Belgium), W. De Wever (Leuven, Belgium)
| |
Deep learning model for the quantification of lung abnormalities in ILD patients
A. Vaidyanathan (Liege, Belgium), F. Belmans (Liege, Belgium), F. Blistein (Liege, Belgium), I. Van Peufflik (Liege, Belgium), W. Vos (Liege, Belgium), S. Walsh (Liege, Belgium), M. Occhipinti (Liege, Belgium), J. Guiot (Liege, Belgium)
| |
Longitudinal lung function assessment of patients hospitalised with COVID-19 using 1H and 129Xe lung MRI
L. Saunders (Sheffield, United Kingdom), G. Collier (Sheffield, United Kingdom), H. Chan (Sheffield, United Kingdom), P. Hughes (Sheffield, United Kingdom), L. Smith (Sheffield, United Kingdom), J. Watson (Sheffield, United Kingdom), Z. Gabriel (Sheffield, United Kingdom), J. Meiring (Sheffield, United Kingdom), M. Plowright (Sheffield, United Kingdom), T. Newman (Sheffield, United Kingdom), J. Eaden (Sheffield, United Kingdom), J. Bray (Sheffield, United Kingdom), H. Marshall (Sheffield, United Kingdom), D. Capener (Sheffield, United Kingdom), L. Armstrong (Sheffield, United Kingdom), J. Rodgers (Sheffield, United Kingdom), M. Brook (Sheffield, United Kingdom), A. Biancardi (Sheffield, United Kingdom), M. Rao (Sheffield, United Kingdom), G. Norquay (Sheffield, United Kingdom), O. Rodgers (Sheffield, United Kingdom), R. Munro (Sheffield, United Kingdom), N. Stewart (Sheffield, United Kingdom), G. Jenkins (London, United Kingdom), J. Grist (Oxford, United Kingdom), F. Gleeson (Oxford, United Kingdom), F. Wilson (Stevenage, United Kingdom), A. Cahn (Stevenage, United Kingdom), A. Swift (Sheffield, United Kingdom), S. Rajaram (Sheffield, United Kingdom), G. Mills (Sheffield, United Kingdom), L. Watson (Sheffield, United Kingdom), P. Collini (Sheffield, United Kingdom), R. Lawson (Sheffield, United Kingdom), R. Thompson (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom)
| |
Patient acceptability of dynamic chest radiography compared to pulmonary function testing>
F. Fyles (Liverpool, United Kingdom), R. Robinson (Liverpool, United Kingdom), F. Shiham (Liverpool, United Kingdom), K. Hunter (Liverpool, United Kingdom), C. Lowe (Liverpool, United Kingdom), H. Burhan (Liverpool, United Kingdom)
| |
Longitudinal chest-CT findings after moderate to critical COVID-19 pneumonia
A. Flikweert (Breda, Netherlands), A. Du Mee (Breda, Netherlands), I. De Backer (Breda, Netherlands), S. van der Sar (Breda, Netherlands)
| |
Association of CT imaging and clinical definitions of chronic bronchitis in the COPD phenotyping study
M. Fat (Los Angeles, United States), S. Park (Goyang, Republic of Korea), F. Abtin (Los Angeles, United States), J. Phillips (Thousand Oaks, United States), J. Belperio (Los Angeles, United States), D. Tashkin (Los Angeles, United States), C. Cooper (Los Angeles, United States), J. Fazio (Los Angeles, United States), I. Barjaktarevic (Los Angeles, United States)
| |
Comparison of 19F-MRI, CT and spirometry in a patient with airways disease
C. Holland (Newcastle upon Tyne (Tyne and Wear), United Kingdom), M. Neal (Newcastle upon Tyne (Tyne and Wear), United Kingdom), B. Pippard (Newcastle upon Tyne (Tyne and Wear), United Kingdom), I. Forrest (Newcastle upon Tyne (Tyne and Wear), United Kingdom), R. Lawson (Sheffield, United Kingdom), H. Fisher (Newcastle upon Tyne, United Kingdom), J. Matthews (Newcastle upon Tyne, United Kingdom), K. Hollingsworth (Newcastle upon Tyne, United Kingdom), A. Simpson (Newcastle upon Tyne, United Kingdom), J. Wild (Sheffield, United Kingdom), P. Thelwall (Sheffield, United Kingdom)
| |